Description

Durability of response data from extended follow-up of microneedling combination therapy patients.

Fig. 11

Chart

Source Paper

Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis.

Archives of dermatological research (2025)

PMID: 40056230

DOI: 10.1007/s00403-025-04032-1

Cite This Figure

![Fig. 11: Durability of response data from extended follow-up of microneedling combination therapy patients.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890238/bin/403_2025_4032_Fig11_HTML.jpg)

> Source: Khalid M A Ahmed et al. "Evaluating the efficacy and safety of combined microneedling therapy versus topi." *Archives of dermatological research*, 2025. PMID: [40056230](https://pubmed.ncbi.nlm.nih.gov/40056230/)

<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890238/bin/403_2025_4032_Fig11_HTML.jpg" alt="Durability of response data from extended follow-up of microneedling combination therapy patients." />
  <figcaption>Fig. 11. Durability of response data from extended follow-up of microneedling combination therapy patients.<br>  Source: Khalid M A Ahmed et al. "Evaluating the efficacy and safety of combined microneedling therapy versus topi." <em>Archives of dermatological research</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40056230/">40056230</a></figcaption>
</figure>

Preuves associées

Minoxidil pour Alopécie Androgénétique

Note A · 299 études

Micro-aiguilles pour Alopécie Androgénétique

Note A · 62 études